Search results
Biotechnology company ProQR has announced that two of its RNA therapy development programmes for inherited sight loss are being acquired by Laboratoires Théa, a company specialising in eye care products.
James was part of #TeamRetinaUK in 2020 when he took part in the first ever Virtual London Marathon. He talks about his experience and his motivation.
Giving a regular monthly or quarterly donation of any amount is a wonderful way to help Retina UK support the inherited sight loss community.
Thursday 26 June 2025, 7.00pm - 8.00pm - via Zoom - Please come and join Mark Baxter and the group for our latest meeting where we will be discussing how to make the most of our home assistants to make our homes smarter and safer.
Wednesday 25 June, 7.00pm - 8.30pm - via Zoom - Come and join Martik and the group for our latest Young Adults online social catch up with our guest speaker Anna Holloway who will be sharing her accessibility tech advice and experience!
Our community is informed and knowledgeable about current research projects into the cause(s) of and treatments for these conditions.
We are delighted to welcome Kathy Evans as our new Chair of Trustees.
Prof Mariya Moosajee at Moorfields Eye Hospital has asked us to share the message below about the clinical trial she is running. This trial is for a treatment that targets a particular section of the USH2A gene.
Tuesday 1 July 2025, 7.00pm - 8.00pm - via Zoom - Please come and join us for our Summer meeting where we are delighted to welcome our guest speaker Rose Woodall, Events Coordinator for the QAC Sight Village events.
As part of our aim to nurture young scientists, we are very pleased to introduce one of our new PhD students as part of a co-funding agreement with the Macular Society.
